Clinical Trial Update: Observational Study Evaluating the Quality of Pegylated Interferon Alfa-2a and Ribavirin Treatment for Chronic Hepatitis C in Cooperation With the BNG (Association of German Resident Gastroenterologists)

View source ↗

Summary

An observational study evaluating pegylated interferon alfa-2a and ribavirin for chronic hepatitis C, with results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Pegasys (pegylated interferon alfa-2a)
• Rebetol (ribavirin)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Chronic Hepatitis C | Status: COMPLETED | Results posted: 2016-09-23